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Abstract
Background: Gliomas are highly aggressive tumors of the nervous system, and current treatments fail to improve
patient survival. To identify substances that can be used as treatments for gliomas, we examined the effect of Celastrus
orbiculatus extract (COE) on the invasion and migration of human glioblastoma U87 and U251 cells in vitro.
Methods: The effects of COE on cell viability and adhesion were tested using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2-H-tetrazolium bromide assay and cell adhesion assay, respectively. The effects of COE on cell migration and
invasion were assessed by a wound-healing assay and transwell migration and invasion assays. The effects of COE on
the expression of epithelial-mesenchymal transition (EMT)-related proteins and matrix metalloproteinases (MMPs) were
evaluated using western blot and gelatin zymography, respectively. Finally, the effect of COE on actin assembly was
observed using phalloidin-tetramethylrhodamine isothiocyanate labeling and confocal laser scanning microscopy.
Results: We found that COE inhibited the adhesion, migration, and invasion of U87 and U251 cells in a dose-
dependent manner. COE reduced N-cadherin and vimentin expression, increased E-cadherin expression, and
reduced MMP-2 and MMP-9 expression in U87 and U251 cells. Furthermore, COE inhibited actin assembly in
U87 and U251 cells.
Conclusions: COE attenuates EMT, MMP expression, and actin assembly in human glioblastoma cells, thereby
inhibiting their adhesion, migration, and invasion in vitro.
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Background
Gliomas are primary brain tumors derived from brain
and spinal glial cells. Because gliomas are highly aggres-
sive, they represent 80 % of all malignant tumors of the
human nervous system and are associated with a high
rate of recurrence [1]. Current treatments for gliomas
include surgery, radiotherapy, and chemotherapy, but
these treatments do not improve patient prognosis and
have major side effects on brain tissue, resulting in me-
dian survival duration of only 9 to 10 months [2]. The
current treatments do not completely remove tumor
cells generated by the glioblastoma, invasion and migra-
tion major leading death [3]. Therefore, it is imperative
to develop drugs that can effectively inhibit the invasion
of glioblastoma cells to improve patient survival. Our
previous studies show that COE inhibits the invasion and
migration of tumor cells in liver cancer [4], gastric cancer
[5], and colorectal cancer [6]. Here, using human glioblast-
oma U87 and U251 cell lines, we examined the effects of
COE on the invasion and migration of glioblastoma cells
and their underlying molecular mechanisms.
Methods
Cell lines and reagents
Human glioblastoma U251 and human malignant
glioblastoma U87 cell lines (Shanghai Cell Bank of the
Chinese Academy of Sciences, Shanghai, China) were
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used. Reagents included Dulbecco’s modified Eagle’s
medium (DMEM; Gibco Inc.), fetal bovine serum (FBS;
Gibco Inc.), trypsin, MTT powder and transwell chamber
(Corning), N-cadherin, E-cadherin, and vimentin anti-
bodies (Santa Cruz Biotechnology), matrix metalloprotein-
ase (MMP)-2 and MMP-9 gelatinase kits (APPLYGEN,
Beijing, China), and cytoskeletal staining kit (Millipore).
Preparation of COE solution
Terpenoids from Celastrus orbiculatus (Batch No:
070510) were purchased from Professor Wang Qiang’s
research group at the Traditional Chinese Medicine In-
stitute of China Pharmaceutical University (Guangzhou,
China) [7]. To extract terpenoids from Celastrus orbicu-
latus, the stem of Celastrus orbiculatus was cut, crushed
into powder, and dried. Reflux extraction was repeated
three times using 95 % ethanol. A rotary evaporator was
used to recover the solvent to obtain the extract. The ex-
tract was added to diatomite, dried in a vacuum at low
temperature, heated and refluxed with ethyl acetate, and
filtered to obtain ethyl acetate extract. Terpenoids made
up 68.3 % of the extract, and the rate of obtaining ex-
tract was approximately 2 %. Concentrated COE solu-
tion was prepared by hydrotropy of the extract using
dimethyl sulfoxide and culture in serum-free medium.
COE solution was filtered and sterilized at atmospheric
pressure for later use.
Instruments
Instruments included a 5 % CO2 incubator (Thermo Fisher
Scientific, MA, USA), automatic enzyme-mark analyzer,
protein electrophoresis chamber, power transfer device
(Bio-Rad Company, CA, USA), SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) gel imaging analyzer (Bio-Rad
Company), inverted fluorescence microscope, and confocal
laser scanning microscope (CLSM; Olympus, Japan).
Cell culture and passage
U251 and U87 cells were cultured with DMEM in a 5 %
CO2 incubator at 37 °C. Cells were observed under an
inverted fluorescence microscope. All cells used in this
study were in the exponential phase.
MTT assay of cell viability
DMEM containing 10 % FBS was used to prepare a
single-cell suspension with a concentration of 3 × 105
cells/mL. The suspension was placed in a 96-well plate
with 100 μL/well. After attachment, cells were randomly
divided into the control group and COE groups. Cells in
COE groups were treated with different concentrations
of COE ranging between 10 and 320 μg/mL, with five
wells for each concentration. After cells were cultured in
a 5 % CO2 incubator at 37 °C for 24, 48, or 72 h, 15 μL
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-
tetrazolium bromide (MTT) was added to each well in
the dark. After 4 h, 100 μL dimethyl sulfoxide was added
after the supernatant was discarded. The absorbance (A)
value was read at 490 nm using a microplate reader. The
experiment was repeated three times. The COE inhib-
ition rate (%) was calculated as [1 - (A of cells in the
COE group/A of cells in the control group)] × 100 %.
The 50 % inhibitory concentration (IC50) was also
calculated.
Cell-matrix adhesion assay
Serum-free DMEM was used to dilute type I collagen
stock solution to 10 μg/mL, which was placed in a 24-
well plate overnight at 4 °C. Type I collagen was blocked
for 1 h using 1 % bovine serum albumin and washed
three times with phosphate-buffered saline (PBS). U87
and U251 cells in COE groups were treated with 20, 40,
or 80 μg/mL COE for 24 h. Cells were starved overnight
in serum-free DMEM, digested, centrifuged, and resus-
pended at a concentration of 3 × 105 cells/mL. Cells were
then plated at a concentration of 3 × 104 cells/mL in the
24-well plate, with three wells for each concentration.
Cells were cultured in a 5 % CO2 incubator at 37 °C for
1 h. The culture solution was then removed from the
24-well plate, and non-adherent cells were washed away
three times with PBS. The remaining cells were fixed for
30 min with 2 % paraformaldehyde, stained with cresyl
violet for 15 min, and observed under an inverted
microscope. The experiment was repeated three times.
Cell adhesion inhibition rate (%) was calculated as (1 –
number of cells in the COE group/number of cells in
the control group) × 100 %.
Cell migration and invasion assays
For the wound-healing assay, U87 and U251 cells were
cultured in DMEM at a concentration of 5 × 105 cells/
mL until cell confluence reached 90 %. Micropipette tips
were used to make linear scratches, and the exfoliated
cells were washed off three times with PBS. The
remaining cells were starved overnight with serum-free
medium to exclude the effect of proliferation on migra-
tion. Cells in COE groups were treated with 20, 40, or
80 μg/mL COE and cultured for another 24 h before
images were taken. The experiment was repeated
three times. The degree of wound healing (%), calcu-
lated as (scratch width of the control group - scratch
width of the COE group)/scratch width of the control
group × 100 %, was used to measure the migration
capacity of cells.
In the transwell invasion assay, matrigel (1:8) was di-
luted with serum-free DMEM, and the basement mem-
brane of the upper chamber of the transwell was coated.
The solution was kept at 37 °C for 1 h to transform the
matrigel aggregate into gel. Cells were prepared at a
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concentration of 5 × 105 cells/mL in serum-free DMEM.
Two hundred μL was added to the upper chamber of
the transwell, and 600 μL culture medium containing
20 % FBS was added to the lower chamber. Cells in the
COE group were treated with 20, 40, or 80 μg/mL COE,
with three wells for each concentration. Cells at each
concentration were cultured in a 24-well plate in a 5 %
CO2 incubator at 37 °C for 24 h. The culture medium in
each well was then discarded, and the chamber was
washed twice with PBS. Cells that did not migrate were
physically cleared from the upper chamber with cotton
swabs. The cells that migrated were fixed with methanol
for 15 min, stained with 0.1 % cresyl violet, washed three
times with PBS, and air-dried. The chamber was inverted
on a microslide and observed under a microscope. Five
fields (200× magnification) were randomly selected for
counting the number of migrated cells, and images were
taken. In the transwell migration assay, matrigel was not
used, otherwise the procedure was the same as that used
in the invasion assay.
E-cadherin, N-cadherin, and vimentin expression
U87 and U251 cells in COE groups were treated with
20, 40, or 80 μg/mL COE. After 24 h, total cellular
protein was extracted. After bicinchoninic acid assay,
SDS-PAGE was performed. Separated protein was trans-
ferred to a polyvinylidene fluoride membrane, kept at
room temperature for 2 h with 5 % skim milk, and incu-
bated at 4 °C overnight with the primary antibody
(1:1000). The corresponding secondary antibody (1:1000)
was added after membrane washing, and protein was in-
cubated at room temperature for 2 h. ECL detection re-
agent was used to develop and detect specific protein
bands.
Gelatin zymography for detecting MMP-2 and MMP-9
activity
Supernatant was collected and cultured. After mixing
with buffer solution at 1:1, 8 % SDS-PAGE containing
1 % gelatin was added, and electrophoresis was per-
formed for 2 h. The gel was washed with 2.5 % Triton
X-100 twice at room temperature for 30 min and
transferred to substrate buffer (10 mmol/L Tris Base,
40 mmol/L Tris-Cl, 0.2 mol/L NaCl, 5 mmol/L CaCl2,
0.02 % Brij 35, pH 7.6). After reaction overnight at 37 °C
and fixation for 2 h, Coomassie blue staining was per-
formed for 20 min. Eluent destaining was performed
until clear digestion bands were observed. Image analysis
was performed on the electrophoresis results.
Immunofluorescence and CLSM for detecting cytoskeletal
organization
Cytoskeletal organization was visualized by using the
actin cytoskeletal and focal adhesion staining kit
(FAK100;Millipore,Billerica,MA). U87 and U251 cells
were placed in a 6-well plate at a concentration of 5 ×
105 cells/mL. When cell confluence reached 50 %, cells
were treated with 80 μg/mL COE for 24 h and then
washed twice with PBS. Cells were fixed immediately
with 4 % paraformaldehyde for 15 min at room
temperature, and then permeabilized in 0.1 M PBS
containing 0.2 % Triton X-100 for 5 min. After being
blocked with 5 % bovine serum albumin, the cells were
immune-labeled with anti-vinculin (1:200) at 37 °C for
1 h. Then, cells were incubated with FITC-anti-mouse
(1:200) and treated with 0.5 μmol/L phalloidin-
tetramethylrhodamine isothiocyanate (TRITC), placed
in the chamber’s cassette for 45 min, then washed
twice with PBS, stained with 6-diamidino-2-phenylin-
dole (DAPI) for 5 min, and mounted with anti-fade
fluorescence mounting medium. The structure of actin
microfilaments and vinculin were evaluated by using
confocal microscope (Olympus, Japan). All images
were obtained under the same conditions of excitation
and registration.
Statistical analysis
Each experiment was repeated at least three times.
Data were analyzed by one-way analysis of variance
using SPSS 16.0 (SPSS Inc., Chicago, IL). Data are
shown as mean ± standard deviation. P-values < 0.05
and P-values < 0.01 means difference were considered
statistically significant.
Results
Effect of COE on viability of human glioblastoma cells
Control U87 and U251 cells exhibited active growth in
vitro, whereas cells treated with varying concentrations
of COE for 24, 48, or 72 h showed significantly inhibited
growth (Fig. 1; P < 0.01). The IC50 for U87 and U251
cells was 107.1 μg/mL and 186.4 μg/mL, respectively.
Therefore, COE concentrations of 20, 40, and 80 μg/mL
were used in subsequent experiments to exclude the
cytotoxic effect of COE on cell adhesion, invasion, and
migration.
Effect of COE on adhesion of human glioblastoma cells
The number of adherent U87 and U251 cells in type
I collagen-containing extracellular matrix (ECM) was
observed after COE treatment for 24 h. COE treat-
ment significantly reduced cell adhesion in a dose-
dependent manner (Fig. 2a-b, *P < 0.05 **P < 0.01).
Effect of COE on invasion and migration of human
glioblastoma cells
In the wound-healing assay, COE treatment for 24 h
significantly inhibited the migration of U87 and
U251 cells in a dose-dependent manner (Fig. 3a-b,
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*P < 0.05 **P < 0.01). Furthermore, in the transwell
migration and invasion assay, COE treatment signifi-
cantly and dose-dependently decreased the number
of transmembrane cells (Fig. 2a-b, *P < 0.05 **P <
0.01), indicating that COE inhibited cell migration
and invasion.
Effect of COE on expression of epithelial-mesenchymal
transition (EMT)-related proteins and MMPs in human
glioblastoma cells
U87 and U251 cells treated with COE for 24 h showed
increased expression of E-cadherin and decreased
expression of N-cadherin and vimentin in a dose-
dependent manner (Fig. 4). Furthermore, COE treat-
ment dose-dependently decreased MMP-2 and MMP-9
expression.
Effect of COE on cytoskeletal organization in human
glioblastoma cells
As illustrated by confocal microscope, both U251 and
U87 cells were immunopositive to F-actin (red) and vin-
culin (green). Treatment with 80 μg/mL COE for 24 h
resulted in a significant collapse in cytoskeletal cytoskel-
etal organization and reduction in the distribution of
vinculin compared with control group (Fig. 5). After
treatment with COE, actin broke progressively, and the
control group maintained with stable and ordered
structure.
Discussion
Gliomas are common intracranial tumors. Gliomas
demonstrate invasive growth and exhibit ill-defined
pathological features, and due to their growth in areas of
the brain that serve important functions, they cannot be
Fig. 1 COE treatment inhibited the viability of U251 and U87 cells by the MTT assay. Cells were incubated with the indicated concentration of
COE for 24 h. Dose- and time-dependent curve of inhibition rate of COE on U251 and U87 cells by the MTT assay. Date were presented as the
means ± SD of three independent experiments performed in quintuplicate. *P < 0.05, **P < 0.01, as compared with the untreated control
Fig. 2 COE treatment for 24 h inhibited the adhesion, invasion and migration of (a) U87 and (b) U251 cells in a dose-dependent manner. Cell
migration and invasion were assessed after 24 h incubation by transwell assay. The cell adhesion ability was performed by the cell adhesion assay.
Top: cresyl violet staining (200× magnification). Bottom: quantification data. Values are expressed as means ± SD of three independent
experiments.*P < 0.05, **P < 0.01, as compared with the untreated control
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completely removed by surgery [8]. The common inva-
sion route of glioblastomas is along basement mem-
branes and medullated fibers.
Invasion and migration are the main biological charac-
teristics associated with tumor malignancy [9]. Liotta et
al. proposed a three-step process of invasion by malig-
nant tumors: tumor cells attach to the ECM, degrade
ECM via proteolytic enzymes, and migrate into the de-
graded matrix [10]. This process can explain how glioma
cells invade adjacent brain tissues in a single-cell man-
ner, grow invasively along basement membranes and
white matter fibers, rarely exhibit blood vessel or lymph-
atic metastasis, and lead to poor prognosis and patient
survival rates [11]. Thus, it is of great significance to
Fig. 3 COE treatment for 24 h inhibited the migration of (a) U87 and (b) U251 cells in a wound-healing assay in a dose-dependent manner. Left:
images of wound-healing assay (200× magnification). Right: quantification data. *P < 0.05, **P < 0.01, as compared to controls
Fig. 4 COE treatment U251 cells for 24 h altered the expression of EMT-related proteins and enzymes in a dose-dependent manner. a: vimentin,
E-cadherin, and N-cadherin expression as shown using western blots. Bottom: quantification data. b: MMP-2 and MMP-9 expression as shown
using gelatin zymography. Bottom: quantification data. *P < 0.05 **P < 0.01, as compared with the untreated control
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control the malignant invasion of glioma cells and
thereby improve patient outcomes.
COE is the product isolated form the plant of
Celastrus orbiculatus, a Chinese traditional herb. We
found that the main effective ingredients extracted from
COE, namely diterpenoids, triterpenoids, and alkaloids,
inhibited tumor cell activity. Our previous studies dem-
onstrate that COE exerts cytotoxic effects, induces apop-
tosis, and inhibits tumor cell adhesion and migration
[12, 13]. Nevertheless, the most effective chemical which
is exerting the anti-cancer function in COE is not clear,
more research was need to find the biologically active
components and corresponding function. In the present
study, we examined the effects of COE on human glio-
blastoma U87 and U251 cell lines using various molecu-
lar biology methods to explore the mechanisms by
which COE acts against human gliomas.
We used the MTT assay to assess cell viability and an
ECM adhesion assay to assess cell adhesion, which may
reflect the potential for cell migration resulting from an
interaction between ECM forces and the movement of
tumor cells. After treatment with COE U87 and U251
cells showed decreased growth and adhesion depending
on the concentration and duration of treatment. These
results indicate that COE could inhibit cell viability,
ECM adhesion, and tumor cell metastases.
Glioblastoma invasion is a complex process that is a
major contributor to poor prognosis. ECM degradation
appears to be the most important feature of this process
[14]. The ECM undergoes continuous remodeling in ac-
tive tissues, during which many proteases, including
MMPs, participate in the destruction of normal brain tis-
sue. MMPs, which are cation-dependent endopeptidases
with high homology, degrade most components of the
ECM [15]. Due to their broad distribution in the human
body and wide range of hydrolysis substrates, MMP-2 and
MMP-9 are regarded as key enzymes for hydrolyzing the
ECM and promoting tumor invasion. To explore whether
COE could inhibit ECM degradation, we used gelatin
zymography to observe MMP-2 and MMP-9 expression
Fig. 5 COE treatment induced cytoskeletal collapse. The organization of the filamentous actin (F-actin, red fluorescence), the distribution of
vinculin (green fluorescence), and the nuclear (blue fluorescence) were observed using confocal fluorescence microscopy (magnification, ×1000;
scale bar, 10 μm).a U251 and U87 cells of control group. b 80 μg/mL COE treated U251 cells
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in U87 and U251 cells. Treatment with COE for 24 h de-
creased MMP-2 and MMP-9 expression. Thus, COE may
inhibit MMP-2 and MMP-9 activity and ECM hydrolysis,
thereby attenuating the invasion and migration of glio-
blastoma cells. Indeed, we also found thatCOE inhibited
the invasion and migration of glioblastoma cells in various
migration and invasion assays.
To further explore the molecular mechanism by which
COE inhibits the invasion and migration of U87 and U251
cells, we assessed the levels of E-cadherin, N-cadherin, and
vimentin, which serve different functions in invasion and
migration. E-cadherin, which is widely distributed in hu-
man epithelial cells and is a member of the calcium-
dependent family of adhesion molecules, mediates intercel-
lular adhesion to maintain the proper morphology and po-
larity of tissues, and participates in intracellular signal
transduction [16]. Intercellular adhesion declines when E-
cadherin expression decreases or is absent, and the removal
of E-cadherin from primary lesions promotes cell invasion
and migration [17]. By contrast, decreased levels of N-
cadherin indicate the recovery of cell polarity and result in
the inhibition of tumor cell invasion and migration [18].
Also, decreased levels of vimentin, are associated with de-
creased migration and invasion of tumor cells [19]. Thus,
changes in levels of E-cadherin, N-cadherin, and vimentin
can serve as indicators of EMT abnormalities [20]. In the
present study, we found that COE treatment increased E-
cadherin expression and decreased N-cadherin and vimen-
tin expression, indicating that COE may inhibit the process
of EMT and the invasion and migration of glioblastoma
cells.
Increased cell motility via cytoskeletal remodeling pro-
motes tumor cell invasion and migration [19, 21]. The
cytoskeletal usually connects to the cytomembrane, influ-
ences interactions between the membrane and ECM, and
controls the activity of membrane receptors and adhesion
plaques of microfilaments to regulate cell movement and
adhesion [15, 16]. F-actin stress bundles (polymerized f-
actin filaments) and focal adhesions are associated with
cell migration and adhesion. Therefore, we evaluated them
by using TRITC-phalloidin fluorescence intensity and
FITC-vinculin, respectively. After treatment with COE,
the F-actin broke progressively, and the focal adhesions
declined dramatically compared with control group. The
results indicate that COE had changes in the human glio-
blastoma cells cytoskeletal structure along with focal ad-
hesions, thereby inhibiting cell migration and adhesion.
Conclusions
COE has dose-dependent effects on cell viability, adhe-
sion, migration, and invasion, as well as the expression of
EMT-related proteins and MMPs in human glioblastoma
U87 and U251 cells. By inhibiting cell viability and the
process of EMT and regulating cytoskeletal organization,
COE could attenuate the adhesion, migration, and
invasion of human glioblastoma cells.
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